Skip to content

Clinical observation of peripheral blood and cerebrospinal fluid in patients with primary central nervous system lymphoma

Clinical observation of peripheral blood and cerebrospinal fluid in patients with primary central nervous system lymphoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113148
Enrollment
Unknown
Registered
2025-11-25
Start date
2025-12-10
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary center nervous system lymphoma

Interventions

Cancer treatmentl group:None

Sponsors

The Fifth Medical Center Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >=18 years, patients with newly diagnosed PCNSL confirmed by pathology; 2. No contraindications for lumbar puncture; 3. The expected survival period is more than 3 months. 4. Before performing specific operations, sign an informed consent form

Exclusion criteria

Exclusion criteria: 1. Secondary CNS Lymphoma; 2. Patients known to be HIV-positive; 3.Use other anti-tumor treatments other than this study(Corticosteroids may be administered, with the requirement that dosage and duration are documented); 4. History of other malignancies that may affect the compliance of the study protocol or the analysis of the results; 5.Pregnant or lactating women;

Design outcomes

Primary

MeasureTime frame
Positivity rate for actionable mutations;Mutations gene;

Countries

China

Contacts

Public ContactHuang Wenrong

The Fifth Medical Center Chinese PLA General Hospital

huangwr301@163.com+86 10 6694 7177

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026